OakChart

Mobia Medical Inc

MOBIHealthcare·Medical Devices·USA·Small·NASD·Nov 11 • 3:59 PM ET

13.47+1.27 (10.41%)
2026-11-12 05:46 CET
Market cap
448.93 USD m
Revenue, TTM
15.62 USD m
Net income, TTM
-17.34 USD m
Free cash flow, TTM
-12.98 USD m
EPS diluted, TTM
-0.52
P/E
-
Compare

Price

MOBI against its 20 and 50-day averages
2050beatmiss
8.0010.0012.0014.001.3M2.5MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26MOBIclose 13.4720-day 10.6050-day 10.0813.4752w high52w low

11.9% under the 52-week high of 15.29 on 17 Jun 2026. 52-week low 8.03 on 19 Oct 2026. Last 15 sessions, 41.6% high to low

Volume 1.32× normal · the line is the 50-bar volume average

Profile

MOBI
52-week range, 75% of the way up
8.0315.29

Mobia Medical, Inc. operates as a commercial-stage medical device company. It engages in developing solutions for stroke recovery survivors with motor impairments. The company was founded by Lawrence James Cauller, Navzer Engineer, Thomas Jordan Curnes II, and William Michael Rosellini on March 5, 2007 and is headquartered in Austin, TX.

IndexRUT
Employees167
IPOMay 08, 2026
ATR, 14d1.00
Rel volume1.32
Short float7.76%
Insider own61.97%
Inst own19.71%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap448.93M
Enterprise Value296.61M
Income-
Sales-
Book/sh4.74
Cash/sh4.82
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees167
IPOMay 08, 2026

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B2.84
P/C2.79
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio11.24
Current Ratio11.79
Debt/Eq0.05
LT Debt/Eq0.05
Option/ShortNo / Yes

Earnings

EPS (ttm)-
EPS next Y-2.66
EPS next Q-0.56
EPS this Y93.72%
EPS next Y22.77%
EPS next 5Y63.05%
EPS past 3/5Y- -
Sales past 3/5Y- -
EPS Y/Y TTM-
Sales Y/Y TTM-
EPS Q/Q-65.13%
Sales Q/Q133.98%
EarningsNov 05 AMC
EPS/Sales Surpr.-13.04% 11.26%

Ownership

Insider Own61.97%
Insider Trans7.05%
Inst Own19.71%
Inst Trans32.28%
ROA-
ROE-
ROIC-
Gross Margin-
Oper. Margin-
Profit Margin-
SMA2027.03%
SMA5033.67%
SMA20017.79%
Trades-

Technical

Shs Outstand33.33M
Shs Float12.67M
Short Float7.76%
Short Ratio4.72
Short Interest0.98M
52W High15.29 -11.90%
52W Low8.03 67.74%
Volatility13.30% 9.28%
ATR (14)1.00
RSI (14)72.27
Beta-
Rel Volume1.32
Avg Volume208.10K
Volume274,686

Performance

Perf Week19.84%
Perf Month58.47%
Perf Quarter15.33%
Perf Half Y11.23%
Perf YTD-3.79%
Perf Year-
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recom1.00
Target Price18.00
Prev Close12.20
Price13.47
Change %10.41%

Analyst ratings

latest 4 of 4
DateActionAnalystRating changeTargetImplied
Jun 02, 2026InitiatedJJP MorganOverweight$15+11.4%
Jun 02, 2026InitiatedGGoldmanBuy$31+130.1%
Jun 02, 2026InitiatedBBTIG ResearchBuy$19+41.1%
Jun 02, 2026InitiatedBBofA SecuritiesBuy$16+18.8%

Peers

Mkt cap
TickerCompanyMkt cap
LIVNLivaNova PLC5.01B
NPCENeuroPace Inc429.73M
ECORElectroCore Inc71.13M
BWAYBrainsway Ltd ADR452.41M
STIMNeuronetics Inc125.92M
INSPInspire Medical Systems Inc1.80B
CLPTClearPoint Neuro Inc293.94M
NYXHNyxoah SA91.66M
PENPenumbra Inc12.68B
RCELAVITA Medical Inc429.73M

Insider trading

14 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Leavitt Chase C.SEE REMARKSSep 11 '26Buy10.302,00020,6005,000Sep 15 04:34 PM
Rawat Prashant B.Chief Operating OfficerSep 02 '26Option Exercise3.3815,00050,70030,000Sep 04 04:28 PM
Tansey Casey MDirectorAug 18 '26Buy12.0716,441198,523318,332Aug 20 09:05 PM
Tansey Casey MDirectorAug 13 '26Buy11.5135,572409,338268,904Aug 17 09:53 PM
Tansey Casey MDirectorAug 17 '26Buy11.8517,166203,433301,891Aug 17 09:53 PM
Tansey Casey MDirectorAug 14 '26Buy11.6615,821184,403284,725Aug 17 09:53 PM
Rawat Prashant B.Chief Operating OfficerJun 10 '26Option Exercise3.3815,00050,70015,000Jun 12 04:20 PM
Curnes Nelson BunkerChief Financial OfficerJun 09 '26Buy12.795,00063,969366,997Jun 11 07:10 PM
Osage University GP III, LLC10% OwnerMay 11 '26Buy15.00533,3337,999,9952,006,716May 12 04:17 PM
Tansey Casey MDirectorMay 11 '26Buy15.0066,666999,990233,332May 11 09:58 PM
HARRINGTON WILLIAM TDirectorMay 11 '26Buy15.00533,3337,999,9952,006,716May 11 09:36 PM
Lucchese Cynthia LDirectorMay 11 '26Buy15.00125,0001,875,000125,000May 11 09:36 PM
Leavitt Chase C.See RemarksMay 11 '26Buy15.003,00045,0003,000May 11 09:36 PM
Mead Dana G Jr.DirectorMay 11 '26Buy15.007,000105,0007,000May 11 09:36 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
IWCiShares Micro-Cap ETFAUM: 1.22B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 111.21M
VTWGVanguard Russell 2000 Growth Index ETFAUM: 1.41B

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-05-0.520-0.460-0.52015.6214.043
2026Q22026-08-11-1.100-0.707-0.63213.5112.173
2026Q12026-06-03-19.305-18.785-0.53412.0612.072
2025Q42026-02-25-15.975--15.98010.78--
2026Q4---0.556--16.043
2027Q1---0.539--17.702
2027Q2---0.523--18.792
2027Q3---0.528--20.922
2027Q4---0.559--22.211
2028Q1---0.552--24.551
2028Q2---0.520--27.501
2028Q3---0.471--30.491
2028Q4---0.502--33.551

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2025FY-54.773--54.78032.01-
2026FY--3.440--57.19
2027FY--2.656--80.03
2028FY--2.762--117.76
2029FY--1.560--172.5
2030FY--0.630--238.8

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0644016.0416.0016.10
2026Q4S2026-11-0540015.3415.0015.80
2026Q4S2026-10-2640015.3415.0015.80
2026Q4S2026-10-1941015.3415.0015.80
2026Q4S2026-08-1241015.3415.0015.80
2026Q4S2026-07-1440015.2215.0015.30
2026Q4S2026-06-0950015.2415.0015.36
2026Q4S2026-06-0350015.2515.0015.36
2026Q4S2026-06-0250015.2515.0015.36
2026Q4S2026-06-0140015.2415.0015.36
2026Q4S2026-05-2920015.3015.3015.30
2026Q4S2026-05-2810015.3015.3015.30
2026Q4R2026-11-06312-0.56-0.58-0.53
2026Q4R2026-11-05300-0.55-0.56-0.54

Estimate history

EPS, annual-0.744-1.405
Period20242025
EPS, quarterly-0.32-0.315-0.344-0.534-0.632-0.521
PeriodQ1 '25Q2 '25Q3 '25Q1 '26Q2 '26Q3 '26
Sales, annual15.64432.041
Period20242025
Sales, quarterly5.6616.6749.01212.07413.50515.616
PeriodQ1 '25Q2 '25Q3 '25Q1 '26Q2 '26Q3 '26
Shares, annual33.08533.08533.326
Period20242025MRQ
Shares, quarterly33.24933.28633.24933.24933.28633.326
PeriodQ1 '25Q2 '25Q3 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY
Total Revenue15.6232.0415.64
Cost of Goods Sold Incl. D&A2.796.223.31
Gross Profit12.8225.8212.34
Selling, General and Administrative Excl. Other31.3572.1936.57
Research and Development2.556.524.24
Other Operating Expense0.000.000.00
Operating Income-18.53-46.37-24.24
Interest Expense0.260.970.97
Unusual Expense0.000.000.00
Net Income Before Taxes-17.34-46.49-24.59
Income Taxes0.000.010.01
Consolidated Net Income-17.34-46.50-24.60
Net Income From Continuing Operations-17.34-46.50-24.60
Net Income-17.34-46.50-24.60
EPS (Recurring)-0.52-1.41-0.74
EPS (Basic, Before Extraordinaries)-0.52-1.41-0.74
EPS (Diluted)-0.52-1.41-0.74
EBITDA-18.35-46.22-24.12
Non-Operating Income (Expense)1.450.840.62
Other After Tax Adjustments0.000.000.00
Stock Option Compensation Expense2.021.140.60
Gross Margin-80.5978.85
Operating Margin--144.71-154.92
Net Margin--145.12-157.26
Shares Outstanding33.3333.0933.09
Market Capitalization448.93448.93-

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q32025Q22025Q1
Total Revenue15.6213.5112.079.016.675.66
Cost of Goods Sold Incl. D&A2.792.402.191.871.221.05
Gross Profit12.8211.109.887.145.464.62
Selling, General and Administrative Excl. Other31.3529.0326.8218.4015.9214.92
Research and Development2.552.281.691.601.421.35
Other Operating Expense0.000.000.000.000.000.00
Operating Income-18.53-17.93-16.94-11.26-10.46-10.30
Interest Expense0.260.250.360.240.240.24
Unusual Expense0.003.920.710.120.65-0.27
Net Income Before Taxes-17.34-21.04-17.74-11.42-10.49-10.65
Income Taxes0.000.000.000.000.000.00
Consolidated Net Income-17.34-21.04-17.74-11.42-10.49-10.65
Net Income From Continuing Operations-17.34-21.04-17.74-11.42-10.49-10.65
Net Income-17.34-21.04-17.74-11.42-10.49-10.65
EPS (Recurring)-0.52-0.55-0.52-0.34-0.30-0.33
EPS (Basic, Before Extraordinaries)-0.52-0.63-0.53-0.34-0.32-0.32
EPS (Diluted)-0.52-0.63-0.53-0.34-0.32-0.32
EBITDA-18.35-17.79-16.88-11.22-10.43-10.27
Non-Operating Income (Expense)1.451.060.270.200.86-0.37
Other After Tax Adjustments0.000.000.000.000.000.00
Stock Option Compensation Expense2.021.270.410.320.320.16
Gross Margin82.1182.2181.8779.2481.7881.52
Operating Margin-118.67-132.74-140.28-124.91-156.73-182.02
Net Margin-111.07-155.82-146.93-126.75-157.18-188.18
Shares Outstanding33.3333.2933.2533.2533.2933.25
Market Capitalization448.93445.54478.12---

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY
Cash & Short Term Investments33.5914.62
Short Term Receivables4.442.83
Inventories5.463.43
Other Current Assets1.940.30
Total Current Assets45.4221.17
Net Property, Plant & Equipment1.740.89
Total Investments and Advances0.000.00
Deferred Tax Assets0.260.09
Other Assets0.990.02
Total Assets48.4122.18
Short Term Debt Incl. Current Port. of LT Debt0.360.02
Accounts Payable2.221.14
Other Current Liabilities7.633.43
Total Current Liabilities10.214.60
Long Term Debt8.087.70
Provision for Risks Charges0.000.00
Deferred Tax Liabilities0.260.09
Other Liabilities0.871.01
Total Liabilities19.4113.39
Non-Equity Reserves0.000.00
Preferred Stock - Carrying Value179.77114.83
Common Equity-150.77-106.04
Total Shareholders Equity29.008.79
Accumulated Minority Interest0.000.00
Total Equity29.008.79
Total Liabilities & Stockholders Equity48.4122.18
Book Value Per Share-4.56-3.20
Tangible Book Value Per Share-4.56-3.20
Full-Time Employees167-
Price to Book Ratio2.84-
Return on Assets-131.74-
Return on Equity-246.09-
Return on Invested Capital-125.41-149.23
Quick Ratio3.923.86
Current Ratio4.454.61

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY
Net Income-17.34-46.50-24.60
Depreciation0.180.150.12
Other Funds (Non Cash)2.581.580.81
Funds from Operations-14.58-44.77-23.68
Extraordinary Item0.000.000.00
Changes in Working Capital1.66-0.92-0.63
Cash from Operating Activities-12.92-45.69-24.32
Capital Expenditures-0.06-0.36-0.04
Net Assets From Acquisitions0.000.000.00
Sale of Fixed Assets and Businesses0.000.000.00
Purchase or Sale of Investments0.000.000.00
Purchase of Investments0.000.000.00
Sale Or Maturity of Investments0.000.000.00
Other Uses0.000.000.00
Other Sources0.000.000.00
Cash from Investing Activities-0.06-0.36-0.04
Cash Dividends Paid0.000.000.00
Preferred Dividends (Cash Flow)0.000.000.00
Change in Capital Stock-3.4265.0315.66
Repurchase of Common Pref Stock0.000.000.00
Sale of Common Pref Stock-3.4265.0315.66
Proceedsfrom Stock Options-3.5464.7114.99
Issuance or Reduction of Debt, Net0.000.000.00
Change in Long Term Debt0.000.000.00
Issuance of Long Term Debt0.000.000.00
Reduction of Long Term Debt0.000.000.00
Net Financing Active Other Cash Flow0.000.000.00
Other Financing Activities Uses0.000.000.00
Cash from Financing Activities-3.4265.0315.66
Net Change in Cash-16.4018.97-8.70
Free Cash Flow-12.98-46.06-24.36
Deferred Taxes & Investment Tax Credit-0.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q32025Q22025Q1
Cash & Short Term Investments160.69177.0955.73---
Short Term Receivables7.005.664.85---
Inventories8.356.956.05---
Other Current Assets2.172.451.59---
Total Current Assets178.22192.1568.22---
Net Property, Plant & Equipment2.802.991.74---
Total Investments and Advances0.000.000.00---
Other Assets0.140.143.64---
Total Assets181.17195.2873.60---
Short Term Debt Incl. Current Port. of LT Debt0.360.360.36---
Accounts Payable3.302.363.03---
Other Current Liabilities11.4611.768.44---
Total Current Liabilities15.1214.4711.83---
Long Term Debt8.018.0748.85---
Provision for Risks Charges0.000.000.00---
Other Liabilities0.130.130.88---
Total Liabilities23.2622.6861.57---
Non-Equity Reserves0.000.000.00---
Preferred Stock - Carrying Value0.000.00179.77---
Common Equity157.91172.61-167.75---
Total Shareholders Equity157.91172.6112.03---
Accumulated Minority Interest0.000.000.00---
Total Equity157.91172.6112.03---
Total Liabilities & Stockholders Equity181.17195.2873.60---
Book Value Per Share4.745.19-5.05---
Tangible Book Value Per Share4.745.19-5.05---
Price to Book Ratio2.84-2.66-2.85---
Return on Invested Capital-10.45-11.65-29.14---
Quick Ratio11.2412.805.25---
Current Ratio11.7913.285.76---

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q32025Q22025Q1
Net Income-17.34-21.04-17.74-11.42-10.49-10.65
Depreciation0.180.140.060.040.030.03
Other Funds (Non Cash)2.585.551.280.530.530.47
Funds from Operations-14.58-15.36-16.41-10.85-9.93-10.15
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital1.66-0.31-1.32-0.74-1.070.42
Cash from Operating Activities-12.92-15.67-17.73-11.59-11.00-9.72
Capital Expenditures-0.06-1.54-0.04-0.240.00-0.02
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.06-1.54-0.04-0.240.00-0.02
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-3.42138.57-0.090.040.0132.42
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock-3.42138.57-0.090.040.0132.42
Proceedsfrom Stock Options-3.54137.95-0.450.000.0032.21
Issuance or Reduction of Debt, Net0.000.0040.000.000.000.00
Change in Long Term Debt0.000.0040.000.000.000.00
Issuance of Long Term Debt0.000.0040.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-3.42138.5739.910.040.0132.42
Net Change in Cash-16.40121.3622.14-11.79-10.9922.68
Free Cash Flow-12.98-17.21-17.77-11.83-11.00-9.75

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-307.76%1.0M12.7M192.89K
2026-10-156.72%0.9M12.7M176.81K
2026-09-308.56%1.1M12.7M176.24K
2026-09-153.71%0.5M12.7M147.55K
2026-08-312.83%0.4M12.7M155.48K
2026-08-143.51%0.4M12.7M145.72K
2026-07-312.92%0.5M16.4M194.41K
2026-07-152.58%0.4M16.4M224.66K
2026-06-307.56%1.2M16.3M252.28K
2026-06-155.24%0.8M15.8M260.34K
2026-05-292.23%0.3M15.4M265.84K
2026-05-152.15%0.3M15.4M555.18K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-10-168-K/A2026-07-30SEC
2026-10-168-K/A2026-07-14SEC
2026-09-154Statement of changes in beneficial ownership of securities2026-09-11SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-08-204Statement of changes in beneficial ownership of securities2026-08-18SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-14SCHEDULE 13GSEC
2026-08-13SCHEDULE 13GSEC
2026-08-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-118-KCurrent report2026-08-11SEC
2026-08-034Statement of changes in beneficial ownership of securities2026-07-30SEC
2026-08-033Initial statement of beneficial ownership of securities2026-07-30SEC
2026-08-038-KCurrent report2026-07-30SEC
2026-07-164Statement of changes in beneficial ownership of securities2026-07-14SEC
2026-07-163Initial statement of beneficial ownership of securities2026-07-14SEC
2026-07-158-KCurrent report2026-07-14SEC
2026-06-294Statement of changes in beneficial ownership of securities2026-05-11SEC
2026-06-294Statement of changes in beneficial ownership of securities2026-05-11SEC
2026-06-294Statement of changes in beneficial ownership of securities2026-05-11SEC
2026-06-294Statement of changes in beneficial ownership of securities2026-05-11SEC
2026-06-294Statement of changes in beneficial ownership of securities2026-05-11SEC
2026-06-293Initial statement of beneficial ownership of securities2026-05-07SEC
2026-06-293Initial statement of beneficial ownership of securities2026-05-07SEC
2026-06-293Initial statement of beneficial ownership of securities2026-05-07SEC
2026-06-293Initial statement of beneficial ownership of securities2026-05-07SEC
2026-06-293Initial statement of beneficial ownership of securities2026-05-07SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-02-23SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-0920.60K100
2026-08995.70K400
2026-070000
2026-0663.97K100
2026-0519.02M600
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
SR ONE CAPITAL MANAGEMENT, LP5.97%
FARALLON CAPITAL MANAGEMENT, L.L.C.3.39%
Aberdeen Group plc2.69%
Avidity Partners Management LP2.40%
DEERFIELD MANAGEMENT COMPANY, L.P.2.02%
PERCEPTIVE ADVISORS LLC1.57%
VANGUARD CAPITAL MANAGEMENT LLC1.34%
Rock Springs Capital Management LP1.26%
BALYASNY ASSET MANAGEMENT L.P.1.17%
GEODE CAPITAL MANAGEMENT, LLC0.77%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND0.96%
abrdn Healthcare Investors0.73%
abrdn Healthcare Opportunities Fund0.60%
abrdn World Healthcare Fund0.42%
VANGUARD EXTENDED MARKET INDEX FUND0.35%
Fidelity Extended Market Index Fund0.15%
Schwab U.S. Small-Cap ETF0.14%
Fidelity Total Market Index Fund0.07%
Fidelity Nasdaq Composite Index Fund0.06%
Fidelity Series Total Market Index Fund0.05%

OakChart. MOBI. Cached 15 minutes.

Some panels did not load: news.